Clinical use of GnRH analogues (Q34693073)

4 August 2017

1 reference

title

Clinical use of GnRH analogues (English)

1 reference

4 August 2017

Kiesel LA

1 reference

4 August 2017

Rody A

series ordinal

1 reference

4 August 2017

Greb RR

series ordinal

1 reference

4 August 2017

Szilágyi A

series ordinal

1 reference

4 August 2017

publication date

1 June 2002

1 reference

4 August 2017

published in

Clinical Endocrinology

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

677-687

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

4 August 2017

1 reference

Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Hormone treatment of endometriosis: the estrogen threshold hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

The efficacy of short-term gonadotrophin-releasing hormone agonists versus human chorionic gonadotrophin to enable oocyte release in gonadotrophin stimulated cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Expression of gonadotropin-releasing hormone (GnRH) gene in human uterine endometrial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

In vitro fertilization and the ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Effects of progesterone on uterine leiomyoma growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Can GnRH agonists act directly on the ovary and contribute to cyst formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Signal transduction of the gonadotropin releasing hormone (GnRH) receptor: cross-talk of calcium, protein kinase C (PKC), and arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

The relevance of asymptomatic endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regimen selection for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Pre- and postoperative hormonal treatment in patients with hysteroscopic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

A double-blind randomised trial of leuprorelin acetate prior to hysterectomy for dysfunctional uterine bleeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01291.X

10.1046/J.1365-2265.2002.01291.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference